Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

MLA

Bouros, Demosthenes, et al. “Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome.” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 12, June 2002, pp. 1581–86. EBSCOhost, https://doi.org/10.1164/rccm.2106012.

APA

Bouros, D., Wells, A. U., Nicholson, A. G., Colby, T. V., Polychronopoulos, V., Pantelidis, P., Haslam, P. L., Vassilakis, D. A., Black, C. M., & du Bois, R. M. (2002). Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. American Journal of Respiratory and Critical Care Medicine, 165(12), 1581–1586. https://doi.org/10.1164/rccm.2106012

Chicago

Bouros, Demosthenes, Athol U Wells, Andrew G Nicholson, Thomas V Colby, Vlasis Polychronopoulos, Panos Pantelidis, Patricia L Haslam, Dimitris A Vassilakis, Carol M Black, and Roland M du Bois. 2002. “Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome.” American Journal of Respiratory and Critical Care Medicine 165 (12): 1581–86. doi:10.1164/rccm.2106012.